Shares of H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) were down 0% during trading on Monday . The company traded as low as $22.00 and last traded at $22.00. Approximately 7,500 shares were traded during trading, an increase of 327% from the average daily volume of 1,758 shares. The stock had previously closed at $22.01.
H. Lundbeck A/S Trading Down 0.0 %
The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15. The company has a market capitalization of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The business has a fifty day moving average price of $22.00 and a 200 day moving average price of $22.00.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- What Investors Need to Know About Upcoming IPOs
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Williams-Sonoma Stock: Buy It and Never Let It Go
- What is the S&P/TSX Index?
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
